Plymouth is world's top recruiter for Covid-19 vaccine trial
So far, more than 1,500 people in Plymouth have registered an interest in taking part
Plymouth's Derriford Hospital is currently the top recruiting site across the world for the international Covid-19 vaccine trial, which launched on Monday (16 November).
The research team at University Hospitals Plymouth NHS Trust have seen record numbers of volunteers register their interest to participate in the trial.
They say they have been taken aback by the willingness of over 1500 residents of Plymouth and the surrounding area, to help in their investigations.
Dr Gary Minto, Director of Research, Development and Innovation at UHP said:
"We are really pleased with how well recruitment to the study is going so far and want to thank everyone who has come forward."
As it stands, the research team at University Hospitals Plymouth have consented, screened and randomised more participants than any other site across the world.
The study, co-funded by the UK government’s Vaccine Taskforce, will test the safety and effectiveness of a new two-dose regimen for a vaccine candidate, developed by The Janssen Pharmaceutical Companies of Johnson & Johnson.
Ann James, Chief Executive of the Trust, said:
"I’d really like to congratulate the Research, Development and Innovation team on this achievement, and to thank those who have signed up to take part in the trial. It’s fantastic news that brings us that bit closer to finding a vaccine, and I’m proud that our Trust is helping to play an important part in the global response to covid-19."
If you would like more information about the study, or are interested in signing up, email: plh-tr.uhpvaccinestudy@nhs.net